STEPHANIE MACKLIN: Open Payments
NPI 1003545773 · RAEFORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 8 payments from 8 companies in 2025. Trend: 2023 $909 · 2024 $2,099 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 1 | $83 |
| Alkermes, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Tris Pharma Inc | 1 | $17 |
Products named: Qelbree, ARISTADA, COBENFY, TRINTELLIX, Auvelity, Quviviq, CAPLYTA, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
